Skip to main navigation Skip to search Skip to main content

Cost-Effectiveness of Apixaban versus Other Direct Oral Anticoagulants and Warfarin in the Prevention of Thromboembolic Complications Among Finnish Patients with Non-Valvular Atrial Fibrillation

  • Taru Hallinen*
  • , Erkki Soini
  • , Christian Asseburg
  • , Miika Linna
  • , Pia Eloranta
  • , Sari Sintonen
  • , Mikko Kosunen
  • *Corresponding author for this work
  • ESiOR Oy
  • Pfizer Oy

Research output: Contribution to journalArticleScientificpeer-review

16 Citations (Scopus)
147 Downloads (Pure)

Search results